appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Prism Medico & Pharmacy reports standalone net loss of Rs 0.07 crore in the December 2021 quarter
2 years ago•Business Standard
Prism Medico & Pharmacy reports standalone net loss of Rs 0.05 crore in the June 2021 quarter
3 years ago•Business Standard
Prism Medico Standalone March 2021 Net Sales At Rs 4.32 Crore, Down 9.57% Y-o-Y
3 years ago•Moneycontrol
Prism Medico & Pharmacy reports standalone net profit of Rs 0.26 crore in the December 2020 quarter
3 years ago•Business Standard
Prism Medico Standalone March 2020 Net Sales At Rs 4.78 Crore, Down 53.12% Y-o-Y
4 years ago•Moneycontrol